ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $149,514 | -2.2% | 5,509 | +10.8% | 0.00% | – |
| Q2 2023 | $152,870 | -8.5% | 4,973 | +7.3% | 0.00% | – |
| Q1 2023 | $167,035 | +25.0% | 4,636 | +37.2% | 0.00% | – |
| Q4 2022 | $133,577 | -16.0% | 3,380 | -14.3% | 0.00% | – |
| Q3 2022 | $159,000 | +12.0% | 3,944 | +16.5% | 0.00% | – |
| Q2 2022 | $142,000 | +6.8% | 3,386 | -1.1% | 0.00% | – |
| Q1 2022 | $133,000 | +51.1% | 3,423 | +54.5% | 0.00% | – |
| Q4 2021 | $88,000 | +340.0% | 2,215 | +276.7% | 0.00% | – |
| Q3 2021 | $20,000 | 0.0% | 588 | +17.1% | 0.00% | – |
| Q2 2021 | $20,000 | +66.7% | 502 | +81.9% | 0.00% | – |
| Q1 2021 | $12,000 | +50.0% | 276 | +72.5% | 0.00% | – |
| Q4 2020 | $8,000 | – | 160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |